Búsqueda | Biblioteca Virtual en Salud

1.

Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?

Figlin, R A; Leibovich, B C; Stewart, G D; Negrier, S.

Ann Oncol ; 29(2): 324-331, 2018 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-29186296

2.

Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma.

Zurita, A J; Gagnon, R C; Liu, Y; Tran, H T; Figlin, R A; Hutson, T E; D'Amelio, A M; Sternberg, C N; Pandite, L N; Heymach, J V.

Br J Cancer ; 117(4): 478-484, 2017 Aug 08.

Artículo en Inglés | MEDLINE | ID: mdl-28683470

3.

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma.

Hutson, T E; Bukowski, R M; Rini, B I; Gore, M E; Larkin, J M; Figlin, R A; Barrios, C H; Escudier, B; Lin, X; Fly, K; Martell, B; Matczak, E; Motzer, R J.

Br J Cancer ; 110(5): 1125-32, 2014 Mar 04.

Artículo en Inglés | MEDLINE | ID: mdl-24434434

4.

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.

Patil, S; Figlin, R A; Hutson, T E; Michaelson, M D; Negrier, S; Kim, S T; Huang, X; Motzer, R J.

Br J Cancer ; 106(10): 1587-90, 2012 May 08.

Artículo en Inglés | MEDLINE | ID: mdl-22568998

5.

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis.

Bracarda, S; Hutson, T E; Porta, C; Figlin, R A; Calvo, E; Grünwald, V; Ravaud, A; Motzer, R; Kim, D; Anak, O; Panneerselvam, A; Escudier, B.

Br J Cancer ; 106(9): 1475-80, 2012 Apr 24.

Artículo en Inglés | MEDLINE | ID: mdl-22441644

6.

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma.

Patil, S; Figlin, R A; Hutson, T E; Michaelson, M D; Négrier, S; Kim, S T; Huang, X; Motzer, R J.

Ann Oncol ; 22(2): 295-300, 2011 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-20657034

7.

Concomitant renal cell carcinoma and chronic myelogenous leukemia: use of a targeted approach.

Pal, S K; Gupta, R K; Dosik, G; Figlin, R A.

Curr Oncol ; 16(2): 44-7, 2009 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-19370179

8.

Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.

Roth, M D; Gitlitz, B J; Kiertscher, S M; Park, A N; Mendenhall, M; Moldawer, N; Figlin, R A.

Cancer Res ; 60(7): 1934-41, 2000 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-10766183

9.

Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.

Reissmann, P T; Koga, H; Takahashi, R; Figlin, R A; Holmes, E C; Piantadosi, S; Cordon-Cardo, C; Slamon, D J.

Oncogene ; 8(7): 1913-9, 1993 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-8390038

10.

Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.

Levin, W J; Press, M F; Gaynor, R B; Sukhatme, V P; Boone, T C; Reissmann, P T; Figlin, R A; Holmes, E C; Souza, L M; Slamon, D J.

Oncogene ; 11(7): 1261-9, 1995 Oct 05.

Artículo en Inglés | MEDLINE | ID: mdl-7478546

11.

Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial.

Vogelzang, N J; Lipton, A; Figlin, R A.

J Clin Oncol ; 11(9): 1809-16, 1993 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-8355047

12.

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

Figlin, R A; Belldegrun, A; Moldawer, N; Zeffren, J; deKernion, J.

J Clin Oncol ; 10(3): 414-21, 1992 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-1482425

13.

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.

Figlin, R A; deKernion, J B; Mukamel, E; Palleroni, A V; Itri, L M; Sarna, G P.

J Clin Oncol ; 6(10): 1604-10, 1988 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-3049952

14.

Improved prognostication of renal cell carcinoma using an integrated staging system.

Zisman, A; Pantuck, A J; Dorey, F; Said, J W; Shvarts, O; Quintana, D; Gitlitz, B J; deKernion, J B; Figlin, R A; Belldegrun, A S.

J Clin Oncol ; 19(6): 1649-57, 2001 Mar 15.

Artículo en Inglés | MEDLINE | ID: mdl-11250993

15.

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

Figlin, R A; Thompson, J A; Bukowski, R M; Vogelzang, N J; Novick, A C; Lange, P; Steinberg, G D; Belldegrun, A S.

J Clin Oncol ; 17(8): 2521-9, 1999 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-10561318

16.

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

Khuri, F R; Rigas, J R; Figlin, R A; Gralla, R J; Shin, D M; Munden, R; Fox, N; Huyghe, M R; Kean, Y; Reich, S D; Hong, W K.

J Clin Oncol ; 19(10): 2626-37, 2001 May 15.

Artículo en Inglés | MEDLINE | ID: mdl-11352954

17.

Measuring the incremental cost of clinical cancer research.

Goldman, D P; Schoenbaum, M L; Potosky, A L; Weeks, J C; Berry, S H; Escarce, J J; Weidmer, B A; Kilgore, M L; Wagle, N; Adams, J L; Figlin, R A; Lewis, J H; Cohen, J; Kaplan, R; McCabe, M.

J Clin Oncol ; 19(1): 105-10, 2001 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-11134202

18.

Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha.

Jacobs, E L; Clare-Salzler, M J; Chopra, I J; Figlin, R A.

J Immunother (1991) ; 10(6): 448-55, 1991 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-1768679

19.

Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection.

Abi-Aad, A S; Figlin, R A; Belldegrun, A; deKernion, J B.

J Immunother (1991) ; 10(4): 292-5, 1991 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-1931865

20.

Biotherapy in clinical practice.

Figlin, R A.

Semin Hematol ; 26(3 Suppl 3): 15-24, 1989 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-2477904

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar: